Nugen Medical Devices Stock Price Prediction
| NGMDF Stock | USD 0.03 0.00 0.00% |
Momentum 9
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of NuGen Medical based on different types of headlines from major news networks to social media. Using NuGen Medical hype-based prediction, you can estimate the value of NuGen Medical Devices from the perspective of NuGen Medical response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in NuGen Medical. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in NuGen Medical to buy its otc stock at a price that has no basis in reality. In that case, they are not buying NuGen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NuGen Medical after-hype prediction price | USD 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NuGen |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NuGen Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NuGen Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of NuGen Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NuGen Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of NuGen Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NuGen Medical Estimiated After-Hype Price Volatility
In the context of predicting NuGen Medical's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NuGen Medical's historical news coverage. NuGen Medical's after-hype downside and upside margins for the prediction period are 0.00 and 4.93, respectively. We have considered NuGen Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NuGen Medical is out of control at this time. Analysis and calculation of next after-hype price of NuGen Medical Devices is based on 3 months time horizon.
NuGen Medical OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as NuGen Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NuGen Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NuGen Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.60 | 4.90 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 20.00 |
|
NuGen Medical Hype Timeline
NuGen Medical Devices is now traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NuGen is forecasted to increase in value after the next headline, with the price projected to jump to 0.03 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 20.0%, whereas the daily expected return is now at -0.6%. The volatility of related hype on NuGen Medical is about 2333333.33%, with the expected price after the next announcement by competition of 0.03. NuGen Medical Devices has accumulated 5.61 M in total debt with debt to equity ratio (D/E) of 7.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. NuGen Medical Devices has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist NuGen Medical until it has trouble settling it off, either with new capital or with free cash flow. So, NuGen Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGen Medical Devices sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGen to invest in growth at high rates of return. When we think about NuGen Medical's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out NuGen Medical Basic Forecasting Models to cross-verify your projections.NuGen Medical Related Hype Analysis
Having access to credible news sources related to NuGen Medical's direct competition is more important than ever and may enhance your ability to predict NuGen Medical's future price movements. Getting to know how NuGen Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NuGen Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CMHSF | Comprehensive Healthcare Systems | 0 | 2 per month | 0.00 | (0.19) | 0.00 | 0.00 | 10.26 | |
| ODYY | Odyssey Group International | 0.00 | 0 per month | 0.00 | (0.01) | 14.29 | (13.10) | 79.09 | |
| NSVGF | Nass Valley Gateway | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ANPCF | ANGLE plc | 0.00 | 0 per month | 0.00 | (0.21) | 0.00 | (9.60) | 47.59 | |
| LIANY | LianBio | 0.00 | 0 per month | 6.72 | 0.1 | 12.73 | (15.15) | 60.61 | |
| INTI | Inhibitor Therapeutics | 0.00 | 0 per month | 6.21 | 0.02 | 14.00 | (15.79) | 68.18 | |
| PMSNF | Proteome Sciences plc | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 300.00 | |
| PMEDF | Predictmedix | 0.00 | 0 per month | 7.16 | 0.09 | 18.00 | (14.29) | 138.29 | |
| PNPL | Pineapple Express | 0.00 | 0 per month | 0.00 | 0.03 | 8.33 | (7.69) | 33.57 | |
| ADMT | Adm Tronics Unltd | 0.00 | 0 per month | 5.99 | 0.01 | 12.50 | (16.67) | 40.40 |
NuGen Medical Additional Predictive Modules
Most predictive techniques to examine NuGen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NuGen using various technical indicators. When you analyze NuGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NuGen Medical Predictive Indicators
The successful prediction of NuGen Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NuGen Medical Devices, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NuGen Medical based on analysis of NuGen Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NuGen Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NuGen Medical's related companies.
Story Coverage note for NuGen Medical
The number of cover stories for NuGen Medical depends on current market conditions and NuGen Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NuGen Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NuGen Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for NuGen OTC Stock analysis
When running NuGen Medical's price analysis, check to measure NuGen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuGen Medical is operating at the current time. Most of NuGen Medical's value examination focuses on studying past and present price action to predict the probability of NuGen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuGen Medical's price. Additionally, you may evaluate how the addition of NuGen Medical to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |